NCT02414373View on ClinicalTrials.gov

Effects of Thoracic Epidural Administered Ropivacaine Versus Bupivacaine on Bladder Function

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

May 15, 2017

Study Completion Date

May 15, 2017

Conditions
Post Operative Urinary Retention
Interventions
DRUG

Ropivacaine 2mg/ml

local anesthetics, which will epidurally administered

DRUG

Bupivacaine

local anesthetics, which will epidurally administered

DEVICE

6 French transurethral dual channel catheter (Gaeltec, Dunvegan, Scotland)

DEVICE

14 French rectal balloon catheter (Gaeltec, Dunvegan, Scotland)

Trial Locations (1)

3010

Patrick Wuethrich, Department of Anaesthesiology and Pain Therapy, University Hospital Bern Inselspital Bern, Bern

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT02414373 - Effects of Thoracic Epidural Administered Ropivacaine Versus Bupivacaine on Bladder Function | Biotech Hunter | Biotech Hunter